Aemetis (NASDAQ:AMTX) Trading 4.3% Higher

Aemetis, Inc. (NASDAQ:AMTX) shares rose 4.3% during mid-day trading on Thursday . The company traded as high as $25.88 and last traded at $25.77. Approximately 7,246 shares traded hands during trading, a decline of 100% from the average daily volume of 4,508,943 shares. The stock had previously closed at $24.70.

Several brokerages have commented on AMTX. Truist Securities started coverage on Aemetis in a research note on Thursday, March 25th. They issued a “buy” rating and a $35.00 target price for the company. Credit Suisse Group initiated coverage on shares of Aemetis in a research report on Monday, March 29th. They issued an “outperform” rating and a $35.00 price objective for the company. Stifel Nicolaus started coverage on shares of Aemetis in a report on Monday, March 15th. They set a “buy” rating and a $25.00 target price on the stock. HC Wainwright increased their target price on shares of Aemetis from $15.00 to $28.00 in a research note on Monday, March 15th. Finally, Truist Financial started coverage on shares of Aemetis in a report on Friday, March 19th. They issued a “buy” rating for the company. One equities research analyst has rated the stock with a sell rating and seven have issued a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $31.60.

The firm has a market capitalization of $709.99 million, a PE ratio of -18.61 and a beta of 0.09. The business’s 50 day moving average is $17.30 and its two-hundred day moving average is $7.12.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings data on Monday, March 15th. The specialty chemicals company reported ($0.68) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.58) by ($0.10). The firm had revenue of $37.33 million for the quarter, compared to analysts’ expectations of $47.34 million. On average, equities research analysts anticipate that Aemetis, Inc. will post -1.73 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently bought and sold shares of the company. Virtu Financial LLC raised its holdings in shares of Aemetis by 389.3% during the 4th quarter. Virtu Financial LLC now owns 130,116 shares of the specialty chemicals company’s stock valued at $324,000 after buying an additional 103,522 shares in the last quarter. HighPoint Advisor Group LLC purchased a new position in shares of Aemetis during the 4th quarter valued at about $197,000. Renaissance Technologies LLC raised its holdings in shares of Aemetis by 57.2% during the 4th quarter. Renaissance Technologies LLC now owns 1,731,349 shares of the specialty chemicals company’s stock valued at $4,311,000 after buying an additional 629,721 shares in the last quarter. Finally, Hussman Strategic Advisors Inc. purchased a new position in shares of Aemetis during the 4th quarter valued at about $76,000. Hedge funds and other institutional investors own 12.89% of the company’s stock.

About Aemetis (NASDAQ:AMTX)

Aemetis, Inc operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products primarily through the conversion of ethanol and biodiesel plants into advanced bio refineries.

Featured Story: How to interpret the current ratio

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.